Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2002-03-27 | From 1987 until his retirement in January 1994, Mr. Bowman was a company group chairman at Johnson & Johnson, with primary responsibility for a group of companies in the diagnostic, blood glucose monitoring and pharmaceutical businesses. |
| 2003-03-27 | Mr. Bowman was a company group chairman at Johnson & Johnson, with primary responsibility for a group of companies in the diagnostic, blood glucose monitoring and pharmaceutical businesses. |
| 2004-03-24 | Jack L. Bowman (age 71) has served as a director of Targeted Genetics since March 1997. Since January 1994, Mr. Bowman has served as a director of NeoRx Corporation and in 2003 he was appointed its chairman and chief executive officer. From 1987 until January 1994, Mr. Bowman was a company group chairman at Johnson & Johnson, with primary responsibility for a group of companies in the diagnostic, blood glucose monitoring and pharmaceutical businesses. From 1980 to 1987, he held various positions at American Cyanamid Company, a pharmaceutical company, most recently as executive vice president. |
| 2005-04-14 | From 1987 to January 1994, Mr. Bowman was a company group chairman at Johnson & Johnson, with primary responsibility for a group of companies in the diagnostic, blood glucose monitoring and pharmaceutical businesses. |
| 2006-03-29 | From 1987 to January 1994, Mr. Bowman was a company group chairman at Johnson & Johnson, with primary responsibility for a group of companies in the diagnostic, blood glucose monitoring and pharmaceutical businesses. |
| 2007-04-02 | Mr. Bowman holds a B.E. in music from Western Washington University and has held executive roles in pharmaceutical and biotechnology companies. |
| 2007-11-21 | Jack L. Bowman - Director |
| 2008-03-28 | Mr. Bowman holds a B.E. in music from Western Washington University. |
Data sourced from SEC filings. Last updated: 2025-10-11